Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
“Today, people from different countries of the world are coming to India for treatment in large numbers. With an aim to further boost medical tourism, the Government of India has launched ‘Heal in India’ program under the leadership of the PM. Similarly, we have started the ‘Heal by India’ program. This will provide an opportunity for our medical workforce to travel all over the world and contribute towards a healthy global society,”
Mansukh Mandaviya
Union Health Minister
Govt of India
Sponsor
Patient Safety Capsules
Time to ban pseudo ads – On World No Tobacco Day 2022 experts have this request and a warning for govt
New Delhi, May 31, 2022: In India, tobacco is known to be a major cause of various chronic diseases, such as cardiovascular disease, lung and oral cancer, etc. According to a report released by the Indian Council of Medical Research, as much as a third of the cancer cases reported in India are linked to tobacco use. Moreover, the number of people diagnosed with cancer is expected to increase to almost 30 million by 2025.
IPC set to release Indian Pharmacopoeia 2022 on July 1
Mumbai, May 31, 2022 : With an aim to boost the highest standards of drugs for use in humans and animals, the Indian Pharmacopoeia Commission (IPC) is all set to release Indian Pharmacopoeia 2022 on July 1, 2022. The IP 2022 will have 92 new monographs, 21 vitamins, minerals, amino acids, fatty acids and 27 active pharmaceutical ingredients (APIs).
Drug Laws & Policy Injections
Health ministry to add 16 drugs as OTC under Schedule K of Drugs Rules, 1945New Delhi, May 27, 2022: The Union health ministry will soon be adding various strengths or delivery forms of 16 drugs, including antipyretic drug paracetamol 500 mg, analgesic diclofenac in ointment format, among others, as over-the-counter (OTC) drugs under Schedule K of Drugs Rules, 1945.
USTR continues to place India on ‘Priority Watch List Mumbai, May 31, 2022: The Office of the United States Trade Representative (USTR) has recently released its Special 301 Report, in which the US agency has continued to place India on the 'Priority Watch List' along with Russia, China, Indonesia, Argenti-na, Chile and Venezuela for lacking requisite IPR protection and enforcement.
Health ministry to relax conditions on liquid antiseptics under Schedule K for limited period of timeNew Delhi, May 27, 2022: The Union ministry of health and family welfare has issued a draft amendment to the rule by which liquid antiseptics for household use were brought under the Schedule K of Drugs Rules, 1945, to exempt it from certain condition till November 30, 2022.
NHA launches public dashboard for Ayushman Bharat Digital MissionNew Delhi, May 30, 2022: The National Health Authority (NHA) under its flagship scheme of Ayushman Bharat Digital Mission (ABDM) has launched a public dashboard for near real-time information on the scheme, an official statement said.
AIOCD seeks 10% trade margin for wholesalers & 20% for retailersumbai, May 27, 2022: The All India Organisation of Chemists and Druggists (AIOCD), a representative body of 9.4 lakh chemists across the country, has urged the National Pharmaceutical Pricing Authority (NPPA) to allow 10 per cent trade margin for wholesalers on price to retailer (PTR) and 20 per cent for retailers on maximum retail price (MRP) of drugs..
Government may 'rationalise' drug trade margins in a bid to reduce costsMay 27, 2022: The government is geared up to apply the trade margin rationalisation (TMR) formula to drugs in order to bring down their prices. At the National Pharmaceutical Pricing Authority's (NPPA's) meeting with stakeholders on the issue last week, the stakeholders were asked to give their suggestions by the end of this week, people in the know told ET.
Pharma Injections
Market for cholesterol drug bempedoic acid to become crowded in India soon: GlobalDataNew Delhi, May 28, 2022: The market for cholesterol drug bempedoic acid in India will become crowded soon, says GlobalData, a leading data and analytics company. Zydus Lifesciences launched a first-in-class oral, non-statin lipid-lowering drug, bempedoic acid, under the brand name Bemdac, for the first time in India in May 2022.
FDI inflow into pharma sector declines 5% in 2021-22New Delhi, May 30, 2022: After recording a 200 per cent growth in Foreign Direct Investment (FDI) equity inflow into the sector in the previous year, foreign equity infusion into the drugs and pharmaceutical industry in India has registered a decline of 5.1 per cent during the fiscal 2021-22.
ICMR calls for proposals for developing tools for improving diagnosis & treatment of venomous snake bite Mumbai, May 30, 2022: The Indian Council of Medical Research (ICMR) has called for proposals for developing novel tools and technologies for improving the diagnosis and treatment of venomous snake bite under the “ICMR-National Task Force for Research on Snake Bite in India.”
Pharma MSMEs seek DoP’s intervention to get input tax credit on penalty paid on excess import quantity under AA Mumbai, May 30, 2022: Small and Medium Pharmaceutical Manufacturers have sought the department of pharmaceuticals (DoP)’s intervention to ensure availability of goods and services tax (GST) credit on GST portal for penalty paid on excess import quantity under Advance Authorization scheme as per paragraph 4.49/4.50 of Hand Book Procedures (HBP).
Pharma companies are now busy adding capacities and seeing a surge in demand for non-Covid drugs May 15, 2022: Over the past two years, as the world was grappling with the dreaded Covid-19 pandemic, BDR Pharmaceuticals, a leading generic pharma company based in Mumbai, was churning out drugs for treating it.
Boehringer Ingelheim gets CDSCO nod for Jardiance to treat for new heart failure indication May 19, 2022: German drug maker Boehringer Ingelheim (BI) on Thursday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to market its drug Jardiance (empagliflozin) in India, for the full spectrum of heart failure diseases regardless of ejection fraction.
Drug Dopes
Hospitals and diagnostic centres witness 39% growth in FDI in 2021-22New Delhi, May 31, 2022 : The hospitals and diagnostic centres sector in the country has reported a growth of 39 per cent in Foreign Direct Investment (FDI) fund infusion during the financial year 2021-22, with fund infusion of around $697.5 million during the year. 
Trivitron develops PCR based kit for Monkeypox virusMumbai, May 28, 2022: The medical devices company Trivitron Healthcare has developed the Real-Time PCR-based kit for the detection of Monkeypox (orthopoxvirus) virus. The World Health Organization's Country Office for India had recently requested the help of the ICMR-National Institute of Virology in Pune to test suspected cases of Monkeypox for SEAR member-states.
SEC recommends permission to Biocon to import and market insulin aspart injection New Delhi, May 28, 2022: The expert panel advising the drug regulator on approvals has recommended grant of permission to import and market Biocon Biologics' insulin aspart injection with waiver of phase III clinical trial in the country with certain conditions.
Medical seat scam unearthed, Telangana cyber crime police arrests kingpin of the gang in Bihar Hyderabad, May 28, 2022: The Hyderabad police busted a gang that was involved in the MBBS medical seat scam and arrested a person named Ashok Shah who was the kingpin of the gang.
India will have distinction of recording highest cardiac deaths by 2030, warns renowned Cardiologist PTI, May 24, 2022: India will have the notorious distinction of recording the highest number of cardiac deaths by 2030 in the world, with virtually every fourth death occurring due to the Cardiovascular Disease (CVD), warned renowned Cardiologist Dr C N Manjunath.
Antibiotics can cause life-threatening fungal infection, says new studyMay 22, 2022: Each year, fungal infections kill nearly the same number of people as tuberculosis each year. The infection takes hold mostly in vulnerable people because they have a defective immune system caused by an underlying disease, such as a viral infection (HIV or Covid-19), or cancer. Antibiotics can cause immune system defects that increase the risk of fungal infections, a new study has found.
National Injections
Pondicherry to establish drug testing lab to augment quality of Ayush products Chennai, May 28, 2022: Following the Central policy to augment the quality of Ayush drugs through the scheme Ayush Oushadhi Gunvatta Evam Uttpadan Samvardhan Yojana (AOGUSY), the Union territory of Pondicherry is going ahead with a plan to establish one drug testing laboratory for ASU&H with grant-in-aid from the Union Ministry of Ayush.
Small scale pharma cos in Madurai feel neglected by TN IDMA and TN PMAChennai, May 30, 2022: Stating that the Tamil Nadu branch of the Indian Drug Manufacturers’ Association (TN IDMA) and the State Pharmaceutical Manufacturers Association (TN PMA) are not taking care of the problems of the few number of small scale formulation units operational in Madurai, a manufacturer belongs to both the associations has alleged that the industry bodies are focusing on the growth of the industries in Chennai only.
Karnataka govt invites Jubilant and Siemens to explore investment opportunities in pharma & medical devices Bengaluru, May 27, 2022: The Karnataka government has invited the Jubilant Group and Siemens to explore the investment opportunities in pharma and medical devices in the state.
TN IDMA calls urgent EC meeting to discuss allegations raised by Madurai entrepreneur Chennai, May 31, 2022: Following the serious allegations raised by the pharma entrepreneur A. Gunasekharan in Madurai against TN IDMA and TN PMA that the pharma MSMEs in Madurai are being ignored by the industry bodies, the state branch of the Indian drug manufacturers association (TN IDMA) has called an emergency executive committee (EC) meeting on May 30, and discussed the issues raised by the entrepreneur.
Government plans to repurpose CoWIN for its Universal Immunisation Programme New Delhi, May 27, 2022: The Union government is planning to repurpose the Co-WIN platform for India’s Universal Immunisation Programme and other national health programmes while continuing with its current function of recording Covid vaccination and issuing certificates. The vaccination record under the Universal Immunisation Programme (UIP) is now maintained manually.
Bayer's consumer health unit plans to step up India play May 31, 2022: The consumer health division of Bayer is betting big on India. The Basel-headquartered drug maker plans to bring more over-the-counter (non-prescription) products specific to Indian consumer needs from its global portfolio and launch more line-extensions of its top brands such as Saridon and Supradyn.
Global Injections
Hepatitis A Outbreak Likely Caused by Strawberries, FDA SaysMay 31, 2022: An outbreak of hepatitis A in the U.S. and Canada could be linked to fresh organic strawberries, according to an FDA alert. So far, 17 cases have been identified in the U.S., with 15 in California and one each in Minnesota and North Dakota.
CDC Issues Travel Alert as WHO Downplays Monkeypox Pandemic RiskMay 31, 2022: The CDC has updated its travel advisory for monkeypox as global cases continue to increase. The risk to the public is still considered low, the CDC said, but travelers should “practice enhanced pre-cautions” and avoid close contact with sick people.
Number of U.S. Child Hepatitis Cases Rises to 180
May 19, 2022: The CDC says 180 children in the United States have been diagnosed with unexplained acute hepatitis, up from 109 cases 2 weeks ago. Most of those newly counted cases were “retrospective” patients, the CDC said in a Wednesday update on the outbreak.
1 in 4 Senior Adult COVID Survivors Experiences Long COVID
May 27, 2022: About 1 in 4 Americans over age 65 and 1 in 5 adults under 65 experienced “long COVID” or “post-COVID” symptoms after surviving a coronavirus infection, according to a new study from the CDC.
Sanofi and Regeneron's pipeline-in-a drug Dupixent nabs priority review for yet another use
June 1, 2022: Sanofi and Regeneron’s Dupixent is on fire. A week after scoring the first FDA approval for eosinophilic esophagitis, the drug scored priority review for prurigo nodularis.
Roche's Evrysdi ramps up SMA rivalry with Novartis and Biogen thanks to FDA nod in newborns
May 31, 2022: Babies that have spinal muscular atrophy now have an at-home treatment option that can help extend their lives. The FDA’s approval of Roche’s Evrysdi opens the oral drug up for infants younger than 2 months old. It was originally approved in August of 2020 for adults and children older than 2 months.
PSAIIF PILL
List of local manufacturers under PPO in no way related to use of govt authorisation under Patent Act: DoP
New Delhi, June 1, 2022: With its list of local suppliers of 209 medicines for public procurement agencies invoked unexpected patent litigations, the Department of Pharmaceuticals (DoP) has informed the Delhi High Court that its effort was merely to collate the details of local manufacturers and it should not be treated as directions by the Government to produce these drugs by infringing patent laws.
ICMR releases SOP for diagnosing and managing anthrax
Mumbai, June 1, 2022: The Indian Council of Medical Research (ICMR), the country’s apex body for promotion of biomedical research, has come out with standard operating procedure (SOP) for anthrax. The SOP will be of tremendous use as a national guideline for handling suspected human, animal and environmental specimens towards diagnosing and managing anthrax.
Frequently Asked Questions
What is West Nile Virus infection?
The West Nile Virus is a mosquito-borne, single-stranded RNA virus. According to the World Health Or-ganization (WHO), it is “a member of the flavivirus genus and belongs to the Japanese Encephalitis anti-genic complex of the family Flaviviridae”. The principal vector for transmission of this virus is the Culex species of mosquitoes. It is transmitted by infected mosquitoes between and among humans and ani-mals, including birds, which are the reservoir host of the virus.. Read More>>>
SUBSCRIBER'S SYMPTOM
Type 2 Diabetes Speeds Aging in the Brain
May 31, 2022: Type 2 diabetes is linked to memory and thinking problems, and a new study suggests it's because the disease makes the brain age faster. Looking at data from 20,000 middle-aged and older adults, researchers found that -- consistent with past studies -- people with type 2 diabetes generally did worse on tests of memory and thinking skills than those without diabetes.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Dr. Harish Tripathi, MBBS "The Prescription" helps give me my monthly dose of current pharma news which I eagerly look forward to in order to keep myself abreast as a more aware reader. Keep up the good work.
Ms Susheela Singh, ProfessionalWant to commend the PSAII India publication team for all the good work they do in bringing out this bi-monthly newsletter. Well done.
Mr Ramamurthy Iyer, Pharma Expert
Very beautifully and aptly captures important news in the Pharma domain. Excellent work.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
